Internal Medicine · Mobile, AL
NPI
1417903113
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1700 Springhill Ave, Suite 100
Mobile, AL, 36604
Phone (251) 435-1200
Groups this clinician bills Medicare through
Medicare paid, 2024
$338K
16,369 services
Medicare patients, 2024
1,038
Average age 79
Drug cost, 2024
$2.8M
36,293 prescriptions
Company payments, 2025
$1,660
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by K K Varden was code J0897 (injection, denosumab, 1 mg), 1,680 times for 19 patients. In total K K Varden billed 16,369 services in 147 codes, and Medicare paid $338K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,680 | 19 | $20.00 | $34K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 768 | 146 | $41.61 | $32K |
| 36415 Venipuncture Blood Collection | Office | 722 | 533 | $8.65 | $6,245 |
| 80053 Clinical Chemistry | Office | 599 | 505 | $10.34 | $6,194 |
| 99213 Office E&M - Established | Office | 590 | 455 | $53.68 | $32K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 576 | 453 | $10.82 | $6,233 |
| 85025 Blood Count | Office | 536 | 446 | $7.61 | $4,079 |
| 80061 Clinical Chemistry | Office | 522 | 461 | $13.10 | $6,837 |
| 99214 Office E&M - Established | Office | 480 | 369 | $75.83 | $36K |
| 84443 Clinical Chemistry | Office | 328 | 284 | $16.41 | $5,382 |
| 83036 Blood Count | Office | 282 | 212 | $9.52 | $2,685 |
| 99309 SNF E&M | Facility | 224 | 56 | $68.93 | $15K |
| 99310 SNF E&M | Office | 219 | 89 | $111.91 | $25K |
| 99309 SNF E&M | Office | 211 | 81 | $67.88 | $14K |
| 84439 Clinical Chemistry | Office | 203 | 169 | $8.83 | $1,793 |
By year: 2022 $301K for 12,801 services; 2023 $324K for 16,407 services; 2024 $338K for 16,369 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 722 | 533 | $8.65 | $6,245 |
| 80053 Clinical Chemistry | 599 | 505 | $10.34 | $6,194 |
| 85025 Blood Count | 536 | 446 | $7.61 | $4,079 |
| 80061 Clinical Chemistry | 522 | 461 | $13.10 | $6,837 |
| 84443 Clinical Chemistry | 328 | 284 | $16.41 | $5,382 |
| 83036 Blood Count | 282 | 212 | $9.52 | $2,685 |
| 84439 Clinical Chemistry | 203 | 169 | $8.83 | $1,793 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 112 | 112 | $18.92 | $2,119 |
| 81001 Clinical Chemistry | 85 | 71 | $3.11 | $264 |
| 82607 Clinical Chemistry | 83 | 77 | $14.78 | $1,227 |
Medicare prescription drug claims, 2024
In 2024, the drug K K Varden prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,681 prescriptions and refills. In total K K Varden wrote 36,293 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,681 | 4,154 | 387 | $19K |
| Atorvastatin Calcium Generic | 1,411 | 3,619 | 365 | $17K |
| Amlodipine Besylate Generic | 1,154 | 2,925 | 318 | $7,683 |
| Pantoprazole Sodium Generic | 1,124 | 2,568 | 306 | $15K |
| Omeprazole Generic | 1,014 | 2,710 | 273 | $18K |
| Losartan Potassium Generic | 880 | 2,330 | 243 | $11K |
| Trazodone Hcl Generic | 744 | 1,747 | 209 | $7,440 |
| Gabapentin Generic | 742 | 1,357 | 199 | $11K |
| Metoprolol Succinate Generic | 656 | 1,631 | 177 | $9,249 |
| Rosuvastatin Calcium Generic | 653 | 1,672 | 181 | $11K |
| Furosemide Generic | 653 | 1,260 | 191 | $3,783 |
| Tamsulosin Hcl Generic | 608 | 1,532 | 163 | $7,700 |
| Metformin Hcl Er Metformin Hcl | 592 | 1,677 | 175 | $5,119 |
| Celecoxib Generic | 536 | 1,097 | 175 | $16K |
| Sertraline Hcl Generic | 505 | 1,080 | 120 | $4,834 |
Brand drugs: 4,131 claims; generic drugs: 32,076 claims; opioid claims: 708.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid K K Varden $1,660 ($1,660 in general payments such as food, travel and fees) from 22 companies. The largest payer was Novo Nordisk Inc with $303.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 24 | $303 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $222 |
| Abbvie Inc. ABBV | 28 | $220 |
| Amgen Inc. AMGN | 24 | $208 |
| Pfizer Inc. PFE | 4 | $94.73 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $81.32 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $60.88 |
| Sanofi Pasteur Inc. SNY | 3 | $55.08 |
| Seqirus USA Inc CSL.AX | 2 | $54.34 |
| GlaxoSmithKline, LLC. GSK | 3 | $48.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.